Founded in 2019 and headquartered in Newton, Massachusetts, Xheme is a biomedical nanotechnology company focused on revolutionizing blood bag technology to extend the shelf life of blood and platelets. Their core mission is to enhance medical and industrial products through innovative, non-toxic additives. Xheme's flagship product, the Xheme Multifunctional Additive (XMA), offers comprehensive protections including anti-oxidation, anti-UV, anti-corrosion, and anti-microbial properties, making it applicable in various markets from healthcare to coatings.
Xheme has garnered attention for its cutting-edge approach to material science, attracting notable investors and industry experts. The company's key achievements include the successful development and commercialization of XMA, which has the potential to significantly impact the medical field by improving blood storage solutions. Overall, Xheme's innovative technologies promise to enhance product longevity and safety across multiple industries, positioning them as a leader in the biomedical nanotechnology space.
